US$ 20.01
pt141 dosage frequency Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction WJMH :: World Journal of
Description
Best and a little more expensive: Stepping up a little in price brings some higher-quality options

The most common are nausea, facial flushing, darkening of moles, headaches, and increased libido

Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repair
Melatonin attenuates aortic endothelial permeability and arteriosclerosis in streptozotocin-induced diabetic rats: possible role of MLCK- and MLCP-dependent MLC phosphorylation
